IDEAYA Biosciences
IDYA
110 hedge funds and large institutions have $820M invested in IDEAYA Biosciences in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 23 reducing their positions, and 8 closing their positions.
238% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 8
109% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 23
21% more funds holding
Funds holding: 91 → 110 (+19)
4.61% more ownership
Funds ownership: 85.59% → 90.2% (+4.6%)
2% less capital invested
Capital invested by funds: $838M → $820M (-$17.6M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$22.3M |
| 2 |
State Street
Boston,
Massachusetts
|
+$15.2M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.53M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.49M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$8.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$17.3M |
| 2 |
BlackRock
New York
|
-$6.55M |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$6.29M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.33M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$5.23M |
IDYA Hedge Fund Activity: Q4 2021 in Review
110 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q4 2021, worth a combined $820M — down 2.1% from $838M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new IDYA positions and 8 closed out — a net gain of 19 holders — while 48 added to existing stakes and 23 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $22.3M. The largest seller was RTW Investments, cutting an estimated $17.3M.
- 110 institutional investors held IDEAYA Biosciences (IDYA) as of Q4 2021, up from 91 in Q3 2021.
- Funds reported $820M of IDEAYA Biosciences stock for Q4 2021, down 2.1% quarter-over-quarter.
- 27 funds opened new IDEAYA Biosciences positions in Q4 2021 and 8 closed out, a net change of +19 holders.
- The largest IDEAYA Biosciences buyer in Q4 2021 was Fidelity Investments, an estimated $22.3M added.
- The largest IDEAYA Biosciences seller in Q4 2021 was RTW Investments, an estimated $17.3M sold.
Based on aggregated 13F filings for Q4 2021.